Safe Pro Group (NASDAQ: SPAI) reported record first-quarter 2026 revenue of $1.22 million, a 560% increase from the prior-year period, driven by…
This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) announced that…
This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in…
Cardio Diagnostics Holdings (NASDAQ: CDIO), a precision medicine company leveraging epigenetics, genetics and artificial intelligence, is poised to meet demands as cardiovascular disease continues…
Oncotelic Therapeutics (OTCQB: OTLC) was featured in a NetworkNewsAudio audio press release focused on emerging opportunities in central nervous system drug delivery, highlighting the…
Research supports the urgent need for more effective tools to identify the risk of cardiovascular disease earlier and guide personalized…
This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI)…
This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB:…
The company’s proprietary FASForm(TM) platform advancing new approach to coal. Frontieras processes coal into multiple commercially valuable outputs, tied to…
Oncotelic Therapeutics (OTCQB: OTLC) reported first-quarter 2026 financial results and a corporate update highlighting continued advancement across its oncology, AI-enabled…